Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLS | AZN | AMGN | GILD | BMY |
| Company | Sellas Life Sciences Group Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 4.91 | 184.36 | 326.03 | 130.44 | 57.65 |
| High | 5.24 | 185.19 | 326.79 | 132.89 | 58.00 |
| Low | 4.90 | 183.12 | 323.21 | 130.00 | 56.93 |
| Latest | 5.09 | 183.41 | 323.57 | 132.43 | 57.30 |
| Change | +0.16 | -1.33 | -6.25 | +0.78 | -0.92 |
| % Change | +3.25% | -0.72% | -1.89% | +0.59% | -1.58% |
| Volume | 2,348,775 | 511,692 | 1,054,082 | 2,603,706 | 4,285,862 |
| 20-Day Average Volume | 4,302,166 | 1,982,100 | 2,498,992 | 5,267,963 | 9,651,544 |
| Previous Close | 4.93 | 184.74 | 329.82 | 131.65 | 58.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.86 | 195.77 | 345.13 | 135.19 | 58.65 |
| 20-Day Raw Stochastic | 66.53% | 6.65% | 3.81% | 31.12% | 9.53% |
| 20-Day Relative Strength | 53.76 | 38.43 | 36.06 | 42.76 | 45.72 |
| Weighted Alpha | +154.64 | +28.00 | +15.28 | +28.73 | +23.78 |
| Today's Opinion | 72% Buy | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 72% Buy | 24% Buy | 8% Sell | 8% Buy | 40% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.59% since 04/27/26 | -2.18% since 04/27/26 | -4.58% since 04/27/26 | +3.65% since 04/27/26 | -0.80% since 04/27/26 |
| Low | 4.66 on 04/29/26 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.96 on 04/30/26 | 56.95 on 05/04/26 |
| High | 5.24 on 05/04/26 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 132.89 on 05/04/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | +22.40% since 04/02/26 | -9.86% since 04/02/26 | -6.71% since 04/02/26 | -5.23% since 04/02/26 | -3.83% since 04/02/26 |
| Low | 4.20 on 04/06/26 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.64 on 04/27/26 | 56.95 on 05/04/26 |
| High | 5.47 on 04/20/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +32.33% since 02/04/26 | -2.14% since 02/04/26 | -11.36% since 02/04/26 | -9.45% since 02/04/26 | -0.53% since 02/04/26 |
| Low | 3.46 on 02/12/26 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 6.14 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +204.52% since 11/04/25 | +11.81% since 11/04/25 | +9.40% since 11/04/25 | +7.65% since 11/04/25 | +25.72% since 11/04/25 |
| Low | 1.39 on 12/02/25 | 162.04 on 11/05/25 | 302.13 on 11/05/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 6.14 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 909,748 | 286,514,752 | 177,998,896 | 163,406,864 | 118,869,808 |
| Shares Outstanding, K | 184,533 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -26,860,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -7,660,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.24 | 0.26 | 0.44 | 0.32 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 03/19/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/12/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.67 | 16.05 | 10.22 |